Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 45: 2013-2014, 1999;
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ledochowski, M.
Right arrow Articles by Fuchs, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ledochowski, M.
Right arrow Articles by Fuchs, D.
Related Collections
Right arrow Molecular Diagnostics and Genetics
(Clinical Chemistry. 1999;45:2013-2014.)
© 1999 American Association for Clinical Chemistry, Inc.


Technical Briefs

Fructose Malabsorption Is Associated with Lower Plasma Folic Acid Concentrations in Middle-Aged Subjects

Maximilian Ledochowski, Florian Überall, Theresia Propst and Dietmar Fuchs
Fructose malabsorption (1)(2), which is frequently seen in the general population, is characterized by the inability to absorb fructose efficiently. As a consequence, fructose reaches the colon where it is broken down by bacteria to short-chain fatty acids, CO2, and H2. Bloating, cramps, osmotic diarrhea, and other symptoms of irritable bowel syndrome are the consequence. It is believed that up to 36% of the European population has fructose malabsorption in a more or less severe form, and approximately one-half of affected individuals are symptomatic (3). We recently found that fructose malabsorption is associated with early signs of mental depression (4). Because folic acid deficiency may contribute to the development of mental depression (5), we examined folic acid concentrations in subjects with fructose malabsorption.

We studied 73 otherwise healthy adults (47 women, 26 men), ages 40–81 years (mean 52.0 years; SD, 9.1 years), who visited physicians' offices for a medical health check-up. None of the patients showed signs of inflammatory bowel disease or any other chronic or infectious diseases, and none was receiving medication. No vitamin supplements were taken because this was an exclusion criterion. Blood samples were collected after an overnight fast. Breath H2 content was measured with a Bedfont gastrolizer (Bedfont) (6)(7). A baseline H2 breath test was performed after a 12-h overnight fast. An oral dose of 50 g of fructose was given in 250 mL of tap water. All tests were performed between 0800 and 0830, and body weight and height were measured. After the fructose load, H2 exhalation was monitored in 30-min intervals for at least 2 h. Maximum H2 exhalation after fructose load was registered, and the differences from baseline ({Delta}H2) were calculated. Fasting plasma samples were drawn into a 5-mL EDTA syringe, and folic acid was measured by an immunoassay (Elecsys System 2010; Boehringer Mannheim) according to the manufacturer's instructions.

The cutoff point for the diagnosis of fructose malabsorption was an increase in breath H2 >20 µL/L above baseline (1)(8). Subjects with increases in breath H2 <=20 µL/L above baseline were considered normal fructose absorbers.

In 46 patients (17 men and 29 women; ages 51.7 ± 9.3 years, mean ± SD), breath H2 concentrations increased >20 µL/L above baseline fasting values; they were therefore classified as fructose malabsorbers. The remaining 27 subjects (9 men and 18 women, ages 52.4 ± 9.1 years) were normal fructose absorbers ({Delta}H2 <20 µL/L). Plasma folic acid was significantly lower in fructose malabsorbers (7.14 ± 2.2 µg/L, mean ± SD) than in normal fructose absorbers (9.1 ± 3.7 µg/L; P <0.01, Student t-test; P <0.02, nonparametric Mann–Whitney U-test; Fig. 1 .). The lower plasma folic acid concentration in fructose malabsorption was independent of sex or age.



View larger version (17K):
[in this window]
[in a new window]
 
Figure 1. Plasma folic acid concentrations in individuals with (FM) and without (CO) fructose malabsorption.

Low plasma folic acid concentrations may be attributable to dietary deficiency or malabsorption of folic acid. Another cause may be an unfavorable bacterial composition in the gut because folic acid derived from colonic bacterial metabolism is a major source of resorbed folic acid. Because malnutrition is highly unlikely in our study population, the lower folic acid concentrations in fructose malabsorbers compared with normals are probably attributable to malabsorption of alimentary folic acid or changes in intestinal bacterial colonization. Fructose malabsorption is known to accelerate gastrointestinal transit when patients are exposed to fructose, thus reducing the contact time that is necessary for the absorption of (micro)nutrients. On the other hand, fructose malabsorption leads to a profound change in bacterial colonization, especially in the colon. Because a substantial amount of folic acid derives from intestinal bacteria, it seems reasonable that a change in the population of gastrointestinal bacteria could lead to a change in the plasma concentrations of folic acid. Fructose malabsorption can be seen in approximately one-third to one-half of the Western European population; therefore, fructose malabsorption could be a major cause of lower folic acid status.

Folic acid deficiency, like vitamin B6 and B12 deficiencies, may increase concentrations of homocysteine (9), which is known to be an additional risk factor for cardiovascular disease (10). Further studies are needed to determine whether fructose malabsorption is indeed associated with increased plasma homocysteine concentrations. In addition, folic acid deficiency has also been shown to increase the risk for development of neural tube defects in newborns (11)(12), and folic acid supplementation was found to reduce the relative risk for the development of colon carcinoma (13). These findings suggest that fructose malabsorption could be a risk factor in the development of these diseases.

Because bacterial metabolism alters folic acid status and intestinal bacterial colonization is altered by nutritional factors and carbohydrate malabsorption syndromes, dietary measurements should not rely solely on folic acid supplementation but should also consider carbohydrate malabsorption syndromes, especially fructose malabsorption. It is suggested that fructose malabsorption be considered in the elderly with folic acid deficiency. Further studies will be necessary to compare not only folic acid concentrations but also homocysteine, vitamin B12, and hematological indices in patients with and without fructose malabsorption.


References

  1. Hoekstra JH, van Kempen AA, Bijl SB, Kneepkens CM. Fructose breath hydrogen tests. Arch Dis Child 1993;68:136-138. [Abstract]
  2. Rumessen JJ. Functional bowel disease: malabsorption and abdominal distress after ingestion of fructose, sorbitol, and fructose-sorbitol mixtures. Gastroenterology 1988;95:694-700. [ISI][Medline] [Order article via Infotrieve]
  3. Born P, Zech J, Stark M, Classen M, Lorenz R. Carbohydrate substitutes: comparative study of intestinal absorption of fructose, sorbitol and xylitol. Med Klin 1994;89:575-578. [Medline] [Order article via Infotrieve]
  4. Ledochowski M, Sperner-Unterweger B, Widner B, Fuchs D. Fructose malabsorption is associated with early signs of mental depression. Eur J Med Res 1998;3:295-298. [Medline] [Order article via Infotrieve]
  5. Kelly GS. Folates: supplemental forms and therapeutic applications. Altern Med Rev 1998;3:208-220. [Medline] [Order article via Infotrieve]
  6. Fleming SC. Evaluation of a hand-held hydrogen monitor in the diagnosis of intestinal lactase deficiency. Ann Clin Biochem 1990;27:499-500.
  7. Duan LP, Braden B, Clement T, Caspary WF, Lembcke B. Clinical evaluation of a miniaturized desktop breath hydrogen analyzer. Z Gastroenterol 1994;32:575-578. [ISI][Medline] [Order article via Infotrieve]
  8. Nelis GF, Vermeeren MA, Jansen W. Role of fructose-sorbitol malabsorption in the irritable bowel syndrome [see comments]. Gastroenterology 1990;99:1016-1020. [ISI][Medline] [Order article via Infotrieve]
  9. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population [see comments]. JAMA 1993;270:2693-2698. [Abstract]
  10. Verhoef P, Stampfer MJ, Buring JE, Graziano JM, Allen RH, Stabler SP, et al. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Am J Epidemiol 1996;143:845-859. [Abstract/Free Full Text]
  11. Rush D. Periconceptional folate and neural tube defect [see comments]. Am J Clin Nutr 1994;59:511S-515S. [Abstract/Free Full Text]
  12. Rieder MJ. Prevention of neural tube defects with periconceptional folic acid. Clin Perinatol 1994;21:483-503. [ISI][Medline] [Order article via Infotrieve]
  13. Giovannucci E, Stampfer MJ, Colditz GA, Hunter DJ, Fuchs C, Rosner BA, et al. Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med 1998;129:517-524. [Abstract/Free Full Text]



The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
M. Ledochowski, B. Widner, C. Murr, and D. Fuchs
Decreased Serum Zinc in Fructose Malabsorbers
Clin. Chem., April 1, 2001; 47(4): 745 - 747.
[Full Text] [PDF]


This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ledochowski, M.
Right arrow Articles by Fuchs, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ledochowski, M.
Right arrow Articles by Fuchs, D.
Related Collections
Right arrow Molecular Diagnostics and Genetics


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS